Pharma Starts a Feedback Loop
Billions are on the table for those who can break out of the mind rubble This is a guest post […]
Billions are on the table for those who can break out of the mind rubble This is a guest post […]
The financial risks of being found liable for patent infringement are astronomically high Developing a strategy for the development, production
There is a strong incentive to find out new opportunities for the discovery of new drugs Annual sales in the
Using drug patent information to synthesize drugs Read Post »
What is Data Exclusivity? In 1984, the USA was the first country to give legal sanctity to data exclusivity via
Drug prices are mysterious and unpredictable for many consumers With the average person’s out-of-pocket expense for a drug determined by
Deconstructing Drug Pricing Strategy for Big Pharma Read Post »
Biologic drugs are far more complex than traditional “small molecule” drugs Generic drugs as we know them differ from biosimilars, which are
Drug repositioning offers an alternative path to drug development Researchers at the US drug group Pfizer’s Sandwich research center while
Using clinical trial information to forecast future therapeutic indications Read Post »
The time and expense involved with introducing a new drug can be phenomenal Whether the “blockbuster drug” era is over,
Leveraging Patent Pending Data for Pharmaceuticals Read Post »
Data from clinical trials can improve pharmaceutical forecasting Pharmaceutical investing requires a level of attention to detail that is not
How Clinical Trial Data Supports Accurate Pharma Forecasting Read Post »